The following educational gaps have been identified to demonstrate need for this journal continuing education activity:
1. Identify the limitations associated with this singlecenter retrospective study.
Identify specific examples when regadenoson would
have an advantage over adenosine or dipyridamole.
3. Discuss the advantages and disadvantages of administering regadenoson at rest, peak exercise, and during walk-recovery. 4. To understand the effects of the timing of regadenoson injection to changes in hemodynamics. 5. To understand the effects of the timing of regadenoson injection to the incidence of vasodilator side effects.
ACCREDITATION AND CONTINUING EDUCATION CREDIT Physicians
The American Society of Nuclear Cardiology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Society of Nuclear Cardiology designates this Journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credits TM . Physicians should only claim credit commensurate with the extent of their participation in the activity.
Technologists
The American Society of Nuclear Cardiology is a recognized provider of continuing education credit for technologists. ASNC's Continuing Education (ACE) credit is accepted by both NMTCB and ARRT. This Journal-based activity has been approved for a maximum of 1 ACE credits for Technologists.
FACULTY DISCLOSURE
As an accredited provider of the Accreditation Council for Continuing Medical Education (ACCME), The American Society of Nuclear Cardiology (ASNC) adheres to the ACCME's 2008 Standards for Commercial Support. In compliance with these standards, it is ASNC's policy to ensure balance, independence, objectivity, and scientific merit in all of its educational activities through the disclosure of relevant relationship with commercial companies. The financial interest or relationships requiring disclosure are outlined in ASNC's CME Conflict of Interest Policy. All authors involved with this activity are required to disclose any relevant financial relationships. The following ASNC staff and article reviewers who were involved in the planning and development of this activity reported no financial relationships: Cathlin Bowman; Jamieson Bourque, MD; Nancy McDonald DeLoatch; J. Askew Wells.
The following article reviewer who was involved in the planning and development of this activity reported a financial relationship Sharmila Dorbala, MD, Grant Research Support, Astellas, Advisory Board, Astellas.
OFF LABEL USE
Articles may include discussion of drugs or devices, or uses of drugs or devices, that have not been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice. ASNC is committed to the free exchange of medical education. Inclusion of any discussion in this program, including discussion on off-label uses, does not imply an endorsement by ASNC of the uses, products, or techniques presented. 
CONTINUING EDUCATION TERM OF APPROVAL

METHOD OF PARTICIPATION
To receive a statement of credit, participants must successfully complete the quiz and evaluation questions after reading and reflecting on the article. The participant selects the single most appropriate answer for each question. A score of 80% or higher is needed to pass the quiz. If less than 80% of the questions were correct, the participant will be notified and may resubmit the quiz with modified answers up to three times. Tests will be graded by ASNC staff members.
Estimated time of completion is 1 hour. 
PROCESSING FEES
ASNC members may claim continuing education credits at no charge. Non-members will be charged $25 per activity. Please fill out the payment area included on the evaluation form.
ACKNOWLEDGEMENT OF COMMERCIAL SUPPORT
This activity is not supported by commercial support.
PRIVACY & CONFIDENTIALITY STATEMENT
ASNC will record learner's personal information as provided on CME evaluations to allow for issuance and tracking of CME certificates. ASNC may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CME program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.
For questions regarding CME content or obtaining CME credit, please contact ASNC at 301.215.7575 or info@asnc.org.
CME QUIZ & REGISTRATION FORM
In order to earn CME credit for this journal activity, you must read the article and successfully pass the posttest. A passing grade of 80% is required to earn credit. CME/ACE certificates will be sent within ten (10) Identify the limitations associated with this single-center retrospective study.
Identify specific examples when regadenoson would have an advantage over adenosine or dipyridamole.
Discuss the advantages and disadvantages of administering regadenoson at rest, peak exercise, and during recovery.
To understand the effects of the timing of Regadenoson injection to changes in hemodynamics.
To understand the effects of the timing of Regadenoson injection to the incidence of vasodilator side effects. 
